SCHEMBL4196222

SCHEMBL4196222

COC(=O)c1n[nH]c(C(=O)N(C)CC(O)c2ccccn2)c1OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HPGD P15428 2/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.37
RECQL P46063 1/20 0.37
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CASP1 P29466 1/20 0.35
NPC1 O15118 1/20 0.35
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
PKM P14618 1/20 0.34
ALPL P05186 1/20 0.34
ALPI P09923 1/20 0.34
ALPG P10696 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4196581 0.89 ALDH1A1 (0.41) ALDH1A1USP2TSHRHSD17B10HPGD
SCHEMBL4196583 0.89 ALDH1A1 (0.41) ALDH1A1USP2TSHRHSD17B10HPGD
SCHEMBL4202447 0.82 LMNA (0.38) ALDH1A1USP2TSHRHSD17B10HPGD
SCHEMBL4205968 0.78 ALDH1A1 (0.56) ALDH1A1USP2TSHRHSD17B10HPGD
SCHEMBL13947735 0.77 HPGD (0.52) ALDH1A1USP2TSHRHSD17B10HPGD
SCHEMBL18655533 0.76 HPGD (0.51) ALDH1A1USP2TSHRHSD17B10HPGD
SCHEMBL4224922 0.75 ALDH1A1 (0.53) ALDH1A1USP2TSHRHSD17B10HPGD
SCHEMBL4205180 0.72 ALDH1A1 (0.55) ALDH1A1USP2TSHRHSD17B10HPGD
SCHEMBL24906243 0.71 LMNA (0.53) ALDH1A1USP2TSHRHSD17B10HPGD
SCHEMBL24906205 0.67 LMNA (0.48) ALDH1A1USP2TSHRHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758585-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-07-22 EP disclosed
US-7476666-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-01-13 US disclosed
US-20080015187-A1 Hiv Integrase Inhibitors MERCK SHARP & DOHME CORP. 2008-01-17 US disclosed
EP-1758585-A2 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2007-03-07 EP disclosed
WO-2005120516-A2 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015187-A1 Hiv Integrase Inhibitors REV1, ZC3HAV1, PNP ALDH1A1 3490/4885USP2 4226/4885TSHR 3017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.